Royalty Pharma plc - Class A —— 资产负债表 (NASDAQ:RPRX) | MetaTrader

展开完整图表

Financials

概览声明统计股息

每季度年度

总资产 16.02 B17.52 B16.81 B16.38 B18.22 B19.62 B 负债总额 6.12 B7.27 B7.29 B6.3 B7.88 B9.91 B 权益总额 9.9 B10.25 B9.53 B10.08 B10.34 B9.71 B 负债及股东权益总额 16.02 B17.52 B16.81 B16.38 B18.22 B19.62 B 总债务 5.82 B7.1 B7.12 B6.14 B7.61 B8.95 B 净债务 3.75 B4.91 B5.38 B5.64 B6.63 B8.31 B

新闻

Can Royalty Pharma (RPRX) Keep the Earnings Surprise Streak Alive?

Revolution Medicines: PDAC Data Wows Wall Street - Jury's Out On Further Upside (RVMD)

Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings

Why Is Mirum Pharmaceuticals (MIRM) Down 3.6% Since Last Earnings Report?

Why Is Apellis Pharmaceuticals (APLS) Down 17.3% Since Last Earnings Report?

Why Is ImmunityBio (IBRX) Down 35.8% Since Last Earnings Report?

Defense Lifts Moat Stocks As Tech Stumbles

Royalty Pharma在TD Cowen会议上展示战略增长洞察

Royalty Pharma at TD Cowen Conference: Strategic Growth Insights

Citizens重申Zymeworks股票评级,基于强劲现金状况

Citizens reiterates Zymeworks stock rating on strong cash position

Zymeworks 2025年业绩显示Ziihera势头强劲推动营收增长176%